Naturally occurring regulatory T cells and interleukins 10 and 12 in the pathogenesis of idiopathic warm autoimmune hemolytic anemia

Journal of Investigational Allergology and Clinical Immunology

Volumn 21, Issue 4, 2011, Pages 297-304

  Ahmad, E ^a   Elgohary, T ^b   Ibrahim, H ^b  

^a Zagazig University   (Egypt)

^b ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

Autoimmune hemolytic anemia; Interleukin10; Interleukin12; Regulatory t cells

Indexed keywords

BILIRUBIN; HAPTOGLOBIN; HEMOGLOBIN; INTERLEUKIN 10; INTERLEUKIN 12; LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDE; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CD4+ CD25+ T LYMPHOCYTE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IDIOPATHIC DISEASE; IMMUNOPATHOGENESIS; IN VITRO STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; REGULATORY T LYMPHOCYTE; RETICULOCYTE COUNT;

ADULT; ANEMIA, HEMOLYTIC, AUTOIMMUNE; CASE-CONTROL STUDIES; CELLS, CULTURED; FEMALE; HAPTOGLOBINS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; RETICULOCYTE COUNT; T-LYMPHOCYTES, REGULATORY;

EID: 79959481850     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Packman CH. Hemolytic anemia due to warm autoantibodies. Blood Rev. 2008; 22:17-31.
2. Dierickx D, De Rycke A, Vanderschueren S, Delannoy A. New treatment options for immune-mediated hematological disorders.Eur J Intern Med.2008;19:579-86.
3. Stahl D, Sibrowski W. Warm autoimmune hemolytic anemia is an IgM-IgG immune complex disease. Autoimmun. 2005; 25:272-782.
4. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH, Identifi cation and functional characterization of human CD4(+) CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med. 2001; 193:1285-94.
5. Becker C, Stoll S, Bopp T, Schmitt E, Helmut J. Regulatory T cells: present facts and future hopes. Med Microbiol Immunol. 2006; 195:113-24.
6. Dejaco C, Duftner C, Grubeck-Loebenstein B, Schirmer M. Imbalance of regulatory T cells in human autoimmune diseases. Immunology. 2006; 117: 289-300.
7. Ng WF, Duggan PJ, Ponchel F, Matarese G, Lombardi G, Edwards AD, Isaacs JD. Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood. 2001; 9:2736-44.
8. Baecher-Allan C, Wolf E, Hafler DA. Functional analysis of highly defi ned FACS isolated populations of human regulatory CD4(+)CD25(+) T cells. Clin Immunol. 2005; 115:10-18.
9. Horwitz DA, Gray JD, Behrendsen SC, Kubin M, Rengaraju M, Ohtsuka K, Trinchieri G. Decreased production of IL-12 and other Th1-type cytokines in patients with recent onset systemic lupus erythematosus. Arthritis Rheum. 1998; 41:838-44.
10. Viallard JF, Pellegrin JL, Ranchin V, Schaeverbeke T, Dehais J, Longy-boursier M, Ragnaud JM, Leng B, Moreau JF. Th1 and Th2 cytokine production by peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin Exp Immunol.1999; 115:189-95.
11. Adorini L. The pathogenic role of IL-12 in TH1-mediated autoimmune diseases. Immunol Immunopharm. 2000; 20: 29-35.
12. Sattler A, Wagner U, Rossol M, Sieper J, Wu P, Krause A, Schmidt WA, Radmer S, Kohler S, Romagnani C, Thiel A. Cytokine-induced human IFN-gamma-secreting effector-memory TH cells in chronic autoimmune infl ammation. Blood. 2009; 26:113:1948-56.
13. + T cells secreting IL-10 and TGF-ß1 mediates suppression in the tumor microenvironment. Clin Cancer Res. 2007; 13: 4345-54.
14. Workman CJ, Szymczak-Workman AL, Collison LW, Pillai MR, Vignali DA. The development and function of regulatory T cells. Mol Life Sci. 2009; 66: 2603-22.
15. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4(+)CD25high regulatory cells in human peripheral blood. J Immunol. 2001;167:1245-53.
16. Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, Shimizu J, Takahashi T, Nomura T. Foxp3+ CD25(+) CD4(+) natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev. 2006;212: 8-27.
17. Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol. 2005; 22: 32-9.
18. Torgerson TR. Regulatory T cells in human autoimmune diseases. Springer Semin Immunopathol. 2006; 28: 63-76.
19. Lanteri MC, O'Brien KM, Purtha WE, Cameron MJ, Lund JM, Owen RE: Tregs control the development of symptomatic West Nile virus infection in humans and mice. J Clin Invest. 2009; 119: 3266-77.
20. Mqadmi A, Zheng X, Yazdanbakhsh K. CD4+CD25+ regulatory T cells control induction of autoimmune hemolytic anemia. Blood. 2005; 105: 3746-8.
21. Zhang XL, Peng J, Sun JZ, Liu JJ, Guo CS, Wang ZG, Yu Y, Shi Y, Qin P, Li SG, Zhang LN, Hou M. De novo induction of plateletspecific CD4+CD25+ regulatory T cells from CD4+CD25- cells in patients with idiopathic thrombocytopenic purpura. Blood. 2009; 11: 2568-77.
22. Lassmann H, Bruck W, Lucchinetti CF. The immunopathology of multiple sclerosis: an overview. Brain Pathol.2007; 17:210-8.
23. Suen JL, Li HT, Jong YJ, Chiang B and Yen JH. Altered homeostasis of CD4+ FoxP3+ regulatory T-cell subpopulations in systemic lupus erythro-matosus. Immunology. 2008; 8:107-23.
24. Möttönen M, Heikkinen J, Mustonen L, Isomäki P, Luukkainen R, Lassila O. CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fl uid of patients with rheumatoid arthritis. Clin Exp Immunol. 2005;140: 360-7.
25. Bacchetta R, Passerini L, Gambineri E, Dai M, Allan SE, Perroni L, Dagna-Bricarelli F, Sartirana C, Matthes-Martin S, Lawitschka A, Azzari C, Ziegler SF, Levings MK, Roncarolo MG. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J Clin Invest. 2006; 116:1713-22.
26. Yan B, Ye S, Chen G, Kuang M, Shen N, Chen S. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha producing antigen-presenting cells. Arthritis Rheum. 2008; 58:801-12.
27. Tang Q, Boden EK, Henriksen KJ, Bour-Jordan H, Bi M, Bluestone JA. Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function. Eur J Immunol. 2004; 34:2996-3005.
28. Nakamura K, Kitani A, Strober W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med. 2001;194: 629-44.
29. Ward FJ, Hall AM, Cairns LS, Leggat AS, Urbaniak SJ, Vickers MA, Barker RN. Clonal regulatory T cells specifi c for a red blood cell autoantigen in human autoimmune hemolytic anemia. Blood. 2008; 15: 680-7.
30. Setoguchi R, Hori S, Takahashi T, Sakaguchi S. Homeostatic maintenance of natural Foxp3+ CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med. 2005; 201:723-35.
31. Zwar TD, van Driel IR, Gleeson PA. Guarding the immune system: suppression of autoimmunity by CD4+CD25+ immunoregulatory T cells. Immunol Cell Biol. 2006; 84: 487-501.
32. Lin SC, Chen KH, Lin CH, Kuo CC, Ling QD, Chan CH. The quantitative analysis of peripheral blood FOXP3- expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Eur J Clin Invest. 2007; 12:987-96.
33. Zhang B, Zhang X, Tang FL, Zhu LP, Lui Y, Lipsky PG. Clinical signifi cance of increased CD4+CD25+ Foxp3+ T cells in patients with new onset systemic lupus erythematosus. Ann Rheum Dis. 2008; 7:1037-40.
34. Toriani-Terenzi C, Pozzetto U, Bianchi M, Fagiolo E. Cytokine network in autoimmune haemolytic anaemia: new probable targets for therapy. Cancer Detection and Prevention. 2002; 26: 292-8.
35. Liorente L, Richaud-Patin Y, García-Padilla C, Claret E, Jakez-Ocampo J, Cardiel MH, Alcocer-Varela J, Grangeot-Keros L, Alarcón-Segovia D, Wijdenes J, Galanaud P, Emilie D. Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthr Rheum. 2000; 43:1790-1800.
36. Fagiolo E, Toriani-Terenzi C. Th1 and Th2 cytokine modulation by IL-10/IL-12 imbalance in autoimmune hemolytic anemia. Autoimmunity. 2002; 35:39-44.
37. Toriani-Terenzi C, Fagiolo E. IL-10 and the Cytokine Network in the Pathogenesis of Human Autoimmune Hemolytic Anemia. Ann. N.Y. Acad. Sci. 2005; 1051: 29-44.
38. Franzke A, Hunger JK, Dittmar KE, Ganser A, Buer J. Regulatory T-cells in the control of immunological diseases. Ann Hematol. 2006; 85: 747-58.
39. Hoyer KK, Kuswanto WF, Gallo E, Abbas AK. Distinct roles of helper T-cell subsets in a systemic autoimmune disease. Blood. 2009; 113: 389-95.